Purchase Order 75F40124P00352

The U.S. Food and Drug Administration (FDA) awarded a $63,966.00 firm fixed-price purchase order contract to Biomedical Device Consultants & Laboratories Of Colorado, LLC (dba BDC Laboratories) for a Heart Valve Pulse Duplicator Test System. The contract, awarded on August 7, 2024, has an ultimate completion date of August 6, 2025 and does not have a set-aside designation. As a civilian agency, the FDA oversees the regulation and approval of medical devices, including heart valves. This contract supports the agency's work in evaluating and testing new heart valve technologies prior to market approval.